Search details
1.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Article
in English
| MEDLINE | ID: mdl-38507751
2.
Rectal Cancer Survival for Residual Carcinoma In Situ Vs. Pathologic Complete Response After Neoadjuvant Therapy.
Dis Colon Rectum
; 2024 Mar 18.
Article
in English
| MEDLINE | ID: mdl-38498775
3.
New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
Curr Opin Obstet Gynecol
; 36(1): 34-39, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38170550
4.
Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor.
Breast Cancer Res
; 25(1): 81, 2023 07 06.
Article
in English
| MEDLINE | ID: mdl-37415239
5.
Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021.
Curr Opin Obstet Gynecol
; 34(1): 41-45, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34967814
6.
Early treatment-related neutropenia predicts response to palbociclib.
Br J Cancer
; 123(6): 912-918, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32641862
7.
Challenges in the clinical utility of the serum test for HER2 ECD.
Biochim Biophys Acta
; 1826(1): 199-208, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22521738
8.
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer.
Hematol Oncol Clin North Am
; 37(1): 103-115, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36435604
9.
Clinical Review on the Management of Hormone Receptor-Positive Metastatic Breast Cancer.
JCO Oncol Pract
; 18(5): 319-327, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34637323
10.
Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis.
Ther Adv Med Oncol
; 14: 17588359221085556, 2022.
Article
in English
| MEDLINE | ID: mdl-35401793
11.
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
NPJ Breast Cancer
; 8(1): 122, 2022 Nov 11.
Article
in English
| MEDLINE | ID: mdl-36369506
12.
A careful reassessment of anthracycline use in curable breast cancer.
NPJ Breast Cancer
; 7(1): 134, 2021 Oct 08.
Article
in English
| MEDLINE | ID: mdl-34625570
13.
Effects of systemic inflammation on relapse in early breast cancer.
NPJ Breast Cancer
; 7(1): 7, 2021 Jan 22.
Article
in English
| MEDLINE | ID: mdl-33483516
14.
Management of ER positive metastatic breast cancer.
Semin Oncol
; 47(5): 270-277, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32958261
15.
Advances in Targeted Therapies for Triple-Negative Breast Cancer.
Drugs
; 79(11): 1217-1230, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31254268
16.
Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer.
Clin Cancer Res
; 25(7): 2072-2079, 2019 04 01.
Article
in English
| MEDLINE | ID: mdl-30635336
17.
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer.
J Target Ther Cancer
; 7(1): 52-69, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29577076
18.
Tumors at the aortoiliac/inferior vena cava bifurcation: preoperative, anesthetic, and intraoperative considerations.
Am Surg
; 73(5): 440-6, 2007 May.
Article
in English
| MEDLINE | ID: mdl-17520995
Results
1 -
18
de 18
1
Next >
>>